Author: Ben Rogers
Scientists Find the ‘Master Switch’ Behind Crohn’s Inflammation
Scientists at Osaka University have identified two proteins that act as ‘master switches’ controlling chronic inflammation in Crohn’s disease. This breakthrough could lead to more targeted treatments that address root causes rather than just managing symptoms.
New Hope for Fibrostenotic Crohn’s: First Treatment in Sight
Palisade Bio receives Health Canada clearance for the first clinical trial targeting fibrostenotic Crohn’s disease specifically. PALI-2108 represents groundbreaking hope for patients who have had limited treatment options, addressing both inflammation and the scar tissue that makes this form of Crohn’s so challenging to treat.
Steroids and Crohn’s: The Relief vs. Risk Reality Check
Steroids can provide rapid relief for Crohn’s flares, but they come with important limitations and risks. We explore the reality of making this treatment decision and what it means for your long-term IBD management strategy.
IL-22: The Body’s Helper That Sometimes Hurts IBD Patients
New research reveals how IL-22, a protein that helps heal the gut, can also fuel inflammation in IBD when levels remain elevated. Understanding this double-edged role could lead to more targeted treatments for Crohn’s and colitis.
RedHill’s Comeback: What Their Recovery Means for IBD Treatment
RedHill Biopharma’s impressive financial recovery after a challenging 2023 offers hope for continued IBD treatment development. Their strategic turnaround demonstrates how pharmaceutical companies can maintain innovation while achieving stability—exactly what our community needs from companies developing treatments that could change our lives.
New Hope: Could Nerve Stimulation Transform IBD Treatment?
Boomerang Medical has raised $20 million to develop a breakthrough device-based treatment for IBD using gentle electrical nerve stimulation. This approach could offer hope for patients seeking alternatives to traditional drug therapies and surgery.
Lincoln’s Take Steps Walk: A Community Coming Together for IBD Hope
Lincoln’s recent Take Steps walk brought the community together to support IBD research and awareness. Beyond fundraising, these events provide crucial resources and community connection for people with Crohn’s disease and ulcerative colitis.
New Stem Cell Research Could Change Surgery Outlook for Crohn’s
New research into mesenchymal stem cell therapy for Crohn’s disease shows promise in reducing the need for repeat surgeries by actually healing damaged tissue rather than just managing symptoms. This regenerative approach could represent a fundamental shift from reactive treatment to true healing for many IBD patients.
New IBD Pregnancy Guidelines Offer Hope for Future Mothers
New global guidelines provide evidence-based recommendations for women with IBD considering pregnancy, offering hope and clear guidance for family planning. Most IBD medications are considered safe during pregnancy, and staying in remission is key to healthy outcomes.
When Matcha Becomes a Risk: IBD Safety Considerations
A young woman’s hospitalization after regular matcha consumption highlights important safety considerations for IBD patients. Understanding the concentrated nature of matcha and quality concerns can help us make informed decisions about incorporating this popular beverage into our routines.
